Results 101 to 110 of about 7,752 (219)
Arquivos de Neuro-Psiquiatria, 2001 BACKGROUND AND OBJECTIVES: Triptans are effective drugs for the acute treatment of migraine. However, 30-40% of the patients commonly present recurrence before 24 hours therefore requiring another dose.
Krymchantowski Abouch V. +1 more
doaj
Étude pharmacoépidémiologique française de l'utilisation des triptans en médecine générale
, 2007 Cette étude pharmacoépidémiologique décrit l'utilisation des triptans en médecine générale, auprès de migraineux "naïfs" (n'ayant jamais utilisé un triptan) et "non naïfs" de triptans (expérience antérieure d'un traitement par cette classe thérapeutique)
Georges Chastan +5 more
core +1 more source
Rational approach to migraine attacks relief
Неврология, нейропсихиатрия, психосоматикаStrategies against migraine attacks include the use of pharmacological agents that are both non-specific and specific for migraine. Despite the wide arsenal of pharmacological agents, effective pain relief is achieved in only one third of migraine ...
G. R. Tabeeva
doaj +1 more source
A COMPARATIVE ANALYSIS OF CLASSICAL TRIPTANS FOR ACUTE MIGRAINE MANAGEMENT
Migraine, a prevalent and debilitating neurological condition, necessitates effective acute treatment options. This study undertakes a comparison of the safety and effectiveness of triptans, 5-hydroxytryptamine1F (5-HT1F) receptor agonists, and ...
SUNIL GUPTA, RAM GOPAL SINGH
core +1 more source
Up to date on the use of triptans for child and adolescent migraine: “the state of the art” [PDF]
, 2001 The introduction of triptans, in the early 1990s, has improved the therapy for acute migraine attack, offering a new quality of life for those patients who suffer from this disabling neurological disorder. Epidemiological data point out that about 10% of
D. CALDERONI +2 more
core
Lessons from triptans in migraine treatment
, 2009 Research for a new antimigraine compound started at Glaxo in 1972 and led to the discovery of the first triptan drug, sumatriptan, a 5-HT1-like receptor agonist with an indolic structure identical to neurotransmitter 5-HT.
E. Sternieri +2 more
core
Les triptans dans la migraine (les nouvelles molécules apportent-elles un bénéfice thérapeutique ?)
, 2003 La maladie migraineuse est source de handicap dans la vie quotidienne, avec altération de la qualité de vie chez de nombreux patients. Depuis quelques années, une nouvelle classe pharmacologique a vu le jour pour le traitement de la crise de migraine ...
OUVRARD, Amandine, GRIMAUD, Nicole
core
Assessment of the efficacy and tolerability of triptans in clinical practice
, 2004 In most cases a triptan is prescribed to a patient suffering from migraine who has been taking OTCAs for years, alone or combined with caffeine, antiemetics, barbiturates, etc.
Leone S +4 more
core
Triptans and Lasmiditan Are Safe and Effective in Patients with Migraine Attacks Associated with Neurodevelopmental Disorders: A Single-Center Prospective Clinical Case Series. [PDF]
Brain SciShibata Y.
europepmc +1 more source